<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35546077</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1933-6926</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>16</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cell adhesion &amp; migration</Title>
          <ISOAbbreviation>Cell Adh Migr</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Triple-negative and triple-positive breast cancer cells reciprocally control their growth and migration via the S100A4 pathway.</ArticleTitle>
        <Pagination>
          <StartPage>65</StartPage>
          <EndPage>71</EndPage>
          <MedlinePgn>65-71</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/19336918.2022.2072554</ELocationID>
        <Abstract>
          <AbstractText>The study's aim was to investigate the S100A4-mediated mechanisms of the regulation of tumor cell proliferation and migration in the human triple-positive breast carcinoma cell line MCF-7 (TPBC) and triple-negative breast carcinoma cell line MDA-MB-231 (TNBC). The proliferative activity of TNBC more than doubled during the incubation in the conditioned medium of TPBC. Extracellular S100A4 dose-dependently decreased the proliferative response of TPBC. TPBC negatively impacted the growth of TNBCs during their co-culturing. TPBC significantly decreased the migration activity of the TNBC cells while the S100A4 intracellular level in the TNBC was also decreasing. The decrease in the S100A4 intracellular level occurred due to the protein's monomeric form while the contribution of the dimeric form into the overall S100A4 concentration in TNBC cells increased 1.5-2-fold. The S100A4 pathway in the intercellular communication between TNBC and TPBCs also included the dexamethasone-sensitive mechanisms of S100A4 intra- and extracellular pools regulation.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dukhanina</LastName>
            <ForeName>Elena A</ForeName>
            <Initials>EA</Initials>
            <Identifier Source="ORCID">0000-0002-2828-9112</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Transcription Factors, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Portseva</LastName>
            <ForeName>Tatiana N</ForeName>
            <Initials>TN</Initials>
            <Identifier Source="ORCID">0000-0002-4341-0697</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Transcription Factors, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dukhanin</LastName>
            <ForeName>Alexander S</ForeName>
            <Initials>AS</Initials>
            <Identifier Source="ORCID">0000-0003-2433-7727</Identifier>
            <AffiliationInfo>
              <Affiliation>Molecular Pharmacology and Radiology Department, Russian National Research Medical University, Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Georgieva</LastName>
            <ForeName>Sofia G</ForeName>
            <Initials>SG</Initials>
            <Identifier Source="ORCID">0000-0003-3665-0390</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Transcription Factors, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cell Adh Migr</MedlineTA>
        <NlmUniqueID>101469464</NlmUniqueID>
        <ISSNLinking>1933-6918</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D017077">Culture Media, Conditioned</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000071999">S100 Calcium-Binding Protein A4</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>142662-27-9</RegistryNumber>
          <NameOfSubstance UI="C077591">S100A4 protein, human</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017077" MajorTopicYN="N">Culture Media, Conditioned</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071999" MajorTopicYN="N">S100 Calcium-Binding Protein A4</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064726" MajorTopicYN="Y">Triple Negative Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Proliferative activity</Keyword>
        <Keyword MajorTopicYN="N">S100A4</Keyword>
        <Keyword MajorTopicYN="N">cell target</Keyword>
        <Keyword MajorTopicYN="N">dexamethasone</Keyword>
        <Keyword MajorTopicYN="N">migration</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>12</Day>
          <Hour>7</Hour>
          <Minute>33</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35546077</ArticleId>
        <ArticleId IdType="pmc">PMC9116394</ArticleId>
        <ArticleId IdType="doi">10.1080/19336918.2022.2072554</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Wilkinson L, Gathani T.. 
Understanding breast cancer as a global health concern. Br J Radiol. 2022;95(1130):20211033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8822551</ArticleId>
            <ArticleId IdType="pubmed">34905391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gründker C, Bauerschmitz G, Schubert A, et al. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH. Int J Oncol. 2016;48(6):2713–2721.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27098123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Santolla MF, Talia M, Maggiolini M. S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC. Cells Int J Mol Sci. 2021;22(9):4720.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8124532</ArticleId>
            <ArticleId IdType="pubmed">33946884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larionov AA. Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients. Front Oncol. 2018;8:89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5894159</ArticleId>
            <ArticleId IdType="pubmed">29670855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baeg S, Park I, Kim J, et al. Comparative Study for Clinical Outcomes of Triple-Positive and Triple-Negative Breast Cancer: long-term Results in 161 Patients Followed in a Single Center. J Breast Dis. 2020;8(1):78–84.</Citation>
        </Reference>
        <Reference>
          <Citation>Egeland EV, Boye K, Park D, et al. Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer. Breast Cancer Res Treat. 2017;162(1):127–137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28058579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prasmickaite L, Tenstad EM, Pettersen S, et al. Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4. Mol Oncol. 2018;12(9):1540–1558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6120223</ArticleId>
            <ArticleId IdType="pubmed">29741811</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nutter F, Holen I, Brown HK, et al. Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line. Endocr Relat Cancer. 2014;21(2):327–341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24413608</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bellahcène A, Bachelier R, Detry C, et al. Transcriptomeanalysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Res Treat. 2007;101(2):135–148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17028989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serrano A, Apolloni S, Rossi S, et al. The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Signals Phenotypes of Microglia: implications for Amyotrophic Lateral Sclerosis. Cells. 2019;8(10):1261.</Citation>
        </Reference>
        <Reference>
          <Citation>Crake LRI, Phillips E, Kleffmann T, et al. Co-culture With Human Breast Adipocytes Differentially Regulates Protein Abundance in Breast Cancer Cells. Cancer Genomics Proteomics. 2019;16(5):319–332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6727076</ArticleId>
            <ArticleId IdType="pubmed">31467226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chik F, Szyf M. Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors. Carcinogenesis. 2011;32(2):224–232.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20980350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dukhanina EA, Lukyanova TI, Romanova EA, et al. Comparative Analysis of Secretion of S100A4 Metastatic Marker by Immune and Tumor Cells. Bull Exp Biol Med. 2008;145(1):85–87.</Citation>
        </Reference>
        <Reference>
          <Citation>Ramagopal UA, Dulyaninova NG, Varney KM, et al. Structure of the S100A4/myosin-IIA complex. BMC Struct Biol. 2013;13(1):31.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3924328</ArticleId>
            <ArticleId IdType="pubmed">24252706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neidhart M, Pajak A, Laskari K, et al. Oligomeric S100A4 Is Associated With Monocyte Innate Immune Memory and Bypass of Tolerance to Subsequent Stimulation With Lipopolysaccharides. Front Immunol. 2019;10:791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6476283</ArticleId>
            <ArticleId IdType="pubmed">31037071</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wessels DJ, Pradhan N, Park YN, et al. Reciprocal signaling and direct physical interactions between fibroblasts and breast cancer cells in a 3D environment. PLoS One. 2019. 
24;14(6):e0218854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6590889</ArticleId>
            <ArticleId IdType="pubmed">31233557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dukhanina EA, Yashin DV, Galkin AV, et al. Unexpected deeds of familiar proteins: interplay of Hsp70, PGRP-S/Tag7 and S100A4/Mts1 in host vs. cancer combat. Cell Cycle. 2010;9(4):676–682.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20107319</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
